BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12376300)

  • 21. Plasma concentration of cytokine antagonists in patients with infection following liver resection.
    Kimura F; Miyazaki M; Suwa T; Sugiura T; Shinoda T; Itoh H; Ambiru S; Shimizu H; Nakagawa K
    Br J Surg; 1998 Dec; 85(12):1631-5. PubMed ID: 9876064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer.
    Muc-Wierzgon M; Nowakowska-Zajdel E; Zubelewicz B; Wierzgon J; Kokot T; Klakla K; Szkilnik R; Wiczkowski A
    J Exp Clin Cancer Res; 2003 Jun; 22(2):171-8. PubMed ID: 12866566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha feto-protein and albumin in ascitic fluid in hepatocellular carcinoma patients.
    Sadek A; Abdel Hady A; el Ayyat A; Hassan M; Mostafa I; Nouh A
    J Egypt Soc Parasitol; 1997 Aug; 27(2):455-64. PubMed ID: 9257984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum levels of soluble tumor necrosis factor receptors as markers for disease progression of human immunodeficiency virus infection].
    Hattori M; Tateyama M; Oishi T; Miyasaka S; Fukutake K
    Rinsho Byori; 1997 Nov; 45(11):1085-90. PubMed ID: 9396350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
    Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
    Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
    Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
    Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.
    Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG
    Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis.
    Junbo H; Li Q; Zaide W; Yunde H
    In Vivo; 1999; 13(2):177-80. PubMed ID: 10363175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study.
    Burger RA; Darcy KM; DiSaia PJ; Monk BJ; Grosen EA; Gatanaga T; Granger GA; Wang J; Tian C; Hanjani P; Cohn DE
    Cancer; 2004 Jul; 101(1):106-15. PubMed ID: 15221995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma.
    Massironi S; Fraquelli M; Paggi S; Sangiovanni A; Conte D; Sciola V; Ciafardini C; Colombo M; Peracchi M
    Dig Liver Dis; 2009 Jan; 41(1):31-5. PubMed ID: 18762462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
    Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J; Zhao CL
    Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
    Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased serum levels of macrophage inflammatory protein-3alpha in hepatocellular carcinoma: relationship with clinical factors and prognostic importance during therapy.
    Yamauchi K; Akbar SM; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2003 May; 11(5):601-5. PubMed ID: 12684696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury.
    Maier B; Lehnert M; Laurer HL; Mautes AE; Steudel WI; Marzi I
    Shock; 2006 Aug; 26(2):122-7. PubMed ID: 16878018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.